TITLE

Therapeutic equivalence of inhaled salbutamol

AUTHOR(S)
FOWLER, STEPHEN J.; LIPWORTH, BRIAN J.
PUB. DATE
April 2000
SOURCE
Thorax;Apr2000, p347
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877309

 

Related Articles

  • Levosalbutamol. Ormrod, D.; Spencer, C.M. // BioDrugs;1999, Vol. 11 Issue 6, p431 

    ▴ Levosalbutamol is a chirally pure β-adrenoceptor agonist developed from racemic salbutamol. ▴ The therapeutically inactive (S)-enantiomer in racemic salbutamol may be associated with increased airway hyperreactivity in patients with asthma. Levosalbutamol aims to provide...

  • Formoterol: An Update of its Pharmacological Properties and Therapeutic Efficacy in the Management of Asthma. Bartow, R.A.; Brogden, R.N. // Drugs;Feb1998, Vol. 55 Issue 2, p303 

    Formoterol, a selective β2-adrenoceptor agonist, produces effective dose-proportional bronchodilation, which persists for up to 12 hours, in patients with reversible obstructive respiratory disease. Bronchodilation is significant within minutes of inhalation, maximal within 2 hours, and at...

  • The Pharmacokinetics of Levosalbutamol: What are the Clinical Implications? Boulton, D.W.; Fawcett, J.P. // Clinical Pharmacokinetics;2001, Vol. 40 Issue 1, p23 

    Salbutamol (albuterol) is a β-adrenoceptor agonist used as a bronchodilator for the treatment of asthma and as a uterine relaxant for the suspension of premature labour. Salbutamol has been marketed as a racemic mixture, although β-agonist activity resides almost exclusively in the...

  • Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Smyth, E.T.; Pavord, I.D.; Wong, C.S.; Wisniewski, A.F.Z.; Williams, J.; Tattersfield, A.E.T. // BMJ: British Medical Journal (International Edition);2/27/93, Vol. 306 Issue 6877, p543 

    Examines the pharmacological interaction of salmeterol and salbutamol on patients with asthma. Effect of adding salbutamol to salmeterol on patients; Potency of salmeterol over salbutamol; Comparison of daily equivalent dosage.

  • Intravenous...agonist in severe acute asthma.  // BMJ: British Medical Journal (International Edition);8/13/88, Vol. 297 Issue 6646, p447 

    Examines the effectiveness of salbutamol in treating severe asthma when given intravenously or by inhalation. Comparison between the effectiveness of intravenous salbutamol and nebulized salbutamol; Change in peak expiratory flow rate; Adverse effects of treatment.

  • Do Inhaled β2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes? Kindermann, Wilfried // Sports Medicine;2007, Vol. 37 Issue 2, p95 

    The prevalence of asthma is higher in elite athletes than in the general population. The risk of developing asthmatic symptoms is the highest in endurance athletes and swimmers. Asthma seems particularly widespread in winter-sport athletes such as cross-country skiers. Asthmatic athletes...

  • Protective effect of inhaled salbutamol powder in children assessed by histamine challenge. Pullan, C.R.; Martin, A.J. // British Medical Journal;2/9/1980, Vol. 280 Issue 6211, p364 

    Examines the effect of inhaled salbutamol powder in children. Administration of placebo controlled trial and inhaled salbutamol powder on children; Assessment of the effect through histamine challenge; Requirement for effectiveness of the dosage; Significance of histamine challenge for...

  • Rescue inhaler goes OTC. Davies, Madlen // Pulse;8/8/2012, Vol. 72 Issue 26, p9 

    The article reports on the availability of salbutamol inhalers over the counter (OTC) in pharmacies across Great Britain.

  • A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol. Radice, Sonia; Milanesi, Anna; Antoniazzi, Stefania; Perrone, Valentina; Carnovale, Carla; Clementi, Emilio // European Journal of Clinical Pharmacology;Nov2011, Vol. 67 Issue 11, p1203 

    A letter to the editor is presented which is concerned with a case of haemorrhagic cystitis caused by inhaled salbutamol and salmeterol.

  • Salbutamol/terbutaline.  // Reactions Weekly;12/19/2015, Vol. 1582 Issue 1, p394 

    The article describes the case of anaphylactic reaction that developed in a patient following inhalation of salbutamol and a paradoxical bronchoconstriction due to terbutaline.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics